Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Medication Adherence Among Nigerians with Schizophrenia: Correlation Between Clinico-Demographic Factors and Quality of Life.

Ogunnubi OP, Olagunju AT, Aina OF, Okubadejo NU.

Ment Illn. 2017 Mar 22;9(1):6889. doi: 10.4081/mi.2017.6889. eCollection 2017 Mar 22.

2.

Dyslipidaemia and Medical Outcome (Health Related Quality of Life) in Patients with Schizophrenia Taking Antipsychotics in Enugu, Nigeria.

Olose EO, Edet J, Igwe MN, Chukwujekwu DC, Aguocha MC, Uwakwe R.

Psychiatry J. 2017;2017:9410575. doi: 10.1155/2017/9410575. Epub 2017 Feb 20.

3.

Bipolar I disorder in remission vs. schizophrenia in remission: Is there a difference in burden?

Esan O, Osunbote C, Oladele O, Fakunle S, Ehindero C, Fountoulakis KN.

Compr Psychiatry. 2017 Jan;72:130-135. doi: 10.1016/j.comppsych.2016.10.009. Epub 2016 Oct 19.

PMID:
27816846
4.

Sociodemographic and clinical correlates of sexual dysfunction among psychiatric outpatients receiving common psychotropic medications in a Neuropsychiatric Hospital in Northern Nigeria.

Olisah VO, Sheikh TL, Abah ER, Mahmud-Ajeigbe AF.

Niger J Clin Pract. 2016 Nov-Dec;19(6):799-806. doi: 10.4103/1119-3077.180063.

5.

The predictors of psychiatric disorders among people living with epilepsy as seen in a Nigerian Tertiary Health Institution.

Ayanda KA, Sulyman D.

Niger Med J. 2016 Jan-Feb;57(1):24-30. doi: 10.4103/0300-1652.180559.

6.

Perception of service satisfaction and quality of life of patients living with schizophrenia in Lagos, Nigeria.

Afe TO, Bello-Mojeed M, Ogunsemi O.

J Neurosci Rural Pract. 2016 Apr-Jun;7(2):216-22. doi: 10.4103/0976-3147.178652.

7.

Quality of life in psychosis: prevalence and associated factors in a Nigerian clinical population.

Lasebikan VO, Owoaje ET.

Community Ment Health J. 2015 May;51(4):491-6. doi: 10.1007/s10597-015-9842-z. Epub 2015 Feb 21.

PMID:
25701078
8.

Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.

Chiliza B, Ojagbemi A, Esan O, Asmal L, Oosthuizen P, Kidd M, Gureje O, Emsley R.

Early Interv Psychiatry. 2016 Feb;10(1):54-62. doi: 10.1111/eip.12141. Epub 2014 Apr 1.

PMID:
24690088
9.

Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.

Akinsulore A, Aloba OO, Mapayi BM, Oloniniyi IO, Fatoye FO, Makanjuola RO.

Soc Psychiatry Psychiatr Epidemiol. 2014 Aug;49(8):1191-8. doi: 10.1007/s00127-014-0838-8. Epub 2014 Feb 19.

PMID:
24549838
10.

Self-stigma, quality of life and schizophrenia: An outpatient clinic survey in Nigeria.

Mosanya TJ, Adelufosi AO, Adebowale OT, Ogunwale A, Adebayo OK.

Int J Soc Psychiatry. 2014 Jun;60(4):377-86. doi: 10.1177/0020764013491738. Epub 2013 Jul 3.

PMID:
23828766
11.

Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia.

Adelufosi AO, Ogunwale A, Abayomi O, Mosanya JT.

Psychiatry Res. 2013 Oct 30;209(3):320-5. doi: 10.1016/j.psychres.2012.12.027. Epub 2013 Feb 27.

PMID:
23452754
12.

A comparative analysis of disability in individuals with bipolar affective disorder and schizophrenia in a sub-Saharan African mental health hospital: towards evidence-guided rehabilitation intervention.

Adegbaju DA, Olagunju AT, Uwakwe R.

Soc Psychiatry Psychiatr Epidemiol. 2013 Sep;48(9):1405-15. doi: 10.1007/s00127-013-0654-6. Epub 2013 Feb 6.

PMID:
23385802
13.

Socio-economic correlates of relapsed patients admitted in a Nigerian mental health institution.

Gbiri CA, Badru FA, Ladapo HT, Gbiri AA.

Int J Psychiatry Clin Pract. 2011 Mar;15(1):19-26. doi: 10.3109/13651501.2010.506954. Epub 2010 Oct 5.

PMID:
22122685
14.

Medication adherence and quality of life among Nigerian outpatients with schizophrenia.

Adelufosi AO, Adebowale TO, Abayomi O, Mosanya JT.

Gen Hosp Psychiatry. 2012 Jan-Feb;34(1):72-9. doi: 10.1016/j.genhosppsych.2011.09.001. Epub 2011 Oct 28.

PMID:
22036736
15.

Subjective life satisfaction and objective living conditions of patients with schizophrenia in Nigeria.

Adewuya AO, Makanjuola RO.

Psychiatr Serv. 2010 Mar;61(3):314-6. doi: 10.1176/ps.2010.61.3.314.

PMID:
20194412
16.

Subjective quality of life of Nigerian schizophrenia patients: sociodemographic and clinical correlates.

Adewuya AO, Makanjuola RO.

Acta Psychiatr Scand. 2009 Aug;120(2):160-4. doi: 10.1111/j.1600-0447.2009.01395.x. Epub 2009 Apr 30.

PMID:
19416124
17.

Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis.

Chisholm D, Gureje O, Saldivia S, Villalón Calderón M, Wickremasinghe R, Mendis N, Ayuso-Mateos JL, Saxena S.

Bull World Health Organ. 2008 Jul;86(7):542-51.

18.

A comparison of quality-of-life in schizophrenia and affective disorder patients in a Nigerian tertiary hospital.

Bamiso Makanjuola A, Ademola Adeponle B, Ayodele Obembe O.

Transcult Psychiatry. 2007 Mar;44(1):65-78.

PMID:
17379611
19.

Subjective quality of life of recently discharged Nigerian psychiatric patients.

Olusina AK, Ohaeri JU.

Soc Psychiatry Psychiatr Epidemiol. 2003 Dec;38(12):707-14.

PMID:
14689175
20.

Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.

Gureje O, Miles W, Keks N, Grainger D, Lambert T, McGrath J, Tran P, Catts S, Fraser A, Hustig H, Andersen S, Crawford AM.

Schizophr Res. 2003 Jun 1;61(2-3):303-14.

PMID:
12729882

Supplemental Content

Loading ...
Support Center